Enhanced striatal β1-Adrenergic receptor expression following hormone loss in adulthood is programmed by both early sexual differentiation and puberty: A study of humans and rats

Endocrinology

Volumn 154, Issue 5, 2013, Pages 1820-1831

  Meitzen, John ^a   Perry, Adam N ^b   Westenbroek, Christel ^b   Hedges, Valerie L ^a   Becker, Jill B ^c   Mermelstein, Paul G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ESTRADIOL; TESTOSTERONE;

ADULTHOOD; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; GONADECTOMY; HUMAN; HUMAN TISSUE; MALE; MENOPAUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUBERTY; QUANTITATIVE ANALYSIS; RAT; SENESCENCE; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADOLESCENT; ADULT; AGING; ANIMALS; CORPUS STRIATUM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HORMONES; HUMANS; MALE; OVARIECTOMY; PUBERTY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; SEX DIFFERENTIATION; TIME FACTORS; UP-REGULATION;

EID: 84876766385     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2131     Document Type: Article

References (90)

1. Diaz Brinton R. Minireview: translational animal models of human menopause: challenges and emerging opportunities. Endocrinology. 2012;153:3571-3578.
2. McCarthyMM.What can development teach us about menopause? Brain Res. 2011;1379:109-118.
3. Berchtold NC, Cribbs DH, Coleman PD, et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A. 2008;105:15605-15610.
4. Sárvári M, Kalló I, Hrabovszky E, et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-Aged, ovariectomized rats. Endocrinology. 2010;151:3847-3862.
5. Bossé R, DiPaolo T. The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause. Cell Mol Neurobiol. 1996;16:199-212.
6. Chisholm NC, Packard AR, Koss WA, Juraska JM. The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats. Endocrinology. 2012;153: 4874-4882.
7. Scarpace PJ, Abrass IB. -And -Adrenergic receptor function in the brain during senescence. Neurobiol Aging. 1988;9:53-58.
8. AhmedEI, Zehr JL, SchulzKM,Lorenz BH, DonCarlos LL, Sisk CL. Pubertal hormones modulate the addition of new cells to sexually dimorphic brain regions. Nat Neurosci. 2008;11:995-997.
9. Bakker J, Baum MJ. Role for estradiol in female-typical brain and behavioral sexual differentiation. Front Neuroendocrinol. 2008;29: 1-16.
10. Gibbs RB. Does short-term estrogen therapy produce lasting benefits in brain? Endocrinology. 2010;151:843-845.
11. Sherwin BB. Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci. 2012;126:123-127.
12. Becker JB. Hormonal influences on sensorimotor function. In: Becker JB, Breedlove SM, Crews D, McCarthyMM,eds. Behavioral Endocrinology. Cambridge, MA: MIT Press; 2002:497-525.
13. Becker JB, Snyder PJ, Miller MM, Westgate SA, Jenuwine MJ. The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacol Biochem Behav. 1987; 27:53-59.
14. Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78:819-824.
15. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology. 1990;15:97-111.
16. Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci. 1988;102:456-459.
17. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol. 1992;49:492-497.
18. Pavon JM, Whitson HE, Okun MS. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas. 2010;65:352-358.
19. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 1999;52:1417-1421.
20. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol. 2008;29:36-47.
21. Chen X, Grisham W, Arnold AP.Xchromosome number causes sex differences in gene expression in adult mouse striatum. Eur J Neurosci. 2009;29:768-776.
22. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci. 1994;5:27-41.
23. Jennes L, Jennes ME, Purvis C, Nees M. c-fos expression in noradrenergic A2 neurons of the rat during the estrous cycle and after steroid hormone treatments. Brain Res. 1992;586:171-175.
24. Leret ML, González MI, Tranque P, Fraile A. Influence of sexual differentiation on striatal and limbic catecholamines. Comp Biochem Physiol C. 1987;86:299-303.
25. Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev. 2004;28:533-546.
26. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 1996;15:17-29.
27. Biegon A, Israeli M. Regionally selective increases in -Adrenergic receptor density in the brains of suicide victims. Brain Res. 1988; 442:199-203.
28. Joyce JN, Lexow N, Kim SJ, et al. Distribution of -Adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse. 1992;10:228-246.
29. Pazos A, Probst A, Palacios JM. -Adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Res. 1985;358: 324-328.
30. van Waarde A, Visser TJ, Elsinga PH, et al. Imaging -Adrenoceptors in the human brain with (S)-1-[18F]fluorocarazolol. J Nucl Med. 1997;38:934-939.
31. Black DJ, Fregly MJ, Thrasher TN, Moreland AF. Reduced -Adrenergic responsiveness in rats treated with estrogenic agents. J Pharmacol Exp Ther. 1976;197:362-370.
32. Thawornkaiwong A, Preawnim S, Wattanapermpool J. Upregulation of -1-Adrenergic receptors in ovariectomized rat hearts. Life Sci. 2003;72:1813-1824.
33. WuQ, Zhao Z, Sun H,HaoYL, Yan CD,GuSL. Oestrogen changed cardiomyocyte contraction and -Adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion. Exp Physiol. 2008;93: 1034-1043.
34. Dent MR, Tappia PS, Dhalla NS. Gender differences in -Adrenoceptor system in cardiac hypertrophy due to arteriovenous fistula. J Cell Physiol. 2011;226:181-186.
35. DentMR,Tappia PS, Dhalla NS. Gender related alterations of-Adrenoceptor mechanisms in heart failure due to arteriovenous fistula. J Cell Physiol. 2012;227:3080-3087.
36. Kam KW, Qi JS, Chen M, Wong TM. Estrogen reduces cardiac injury and expression of -1-Adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther. 2004;309:8-15.
37. Biegon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 1983;32:2015-2021.
38. Petrovic SL, McDonald JK, De Castro JC, Snyder GD, McCann SM. Regulation of anterior pituitary and brain-Adrenergic receptors by ovarian steroids. Life Sci. 1985;37:1563-1570.
39. Etgen AM, Ansonoff MA, Quesada A. Mechanisms of ovarian steroid regulation of norepinephrine receptor-mediated signal transduction in the hypothalamus: implications for female reproductive physiology. Horm Behav. 2001;40:169-177.
40. Herbison AE, Simonian SX, Thanky NR, Bicknell RJ. Oestrogen modulation of noradrenaline neurotransmission. Novartis Found Symp. 2000;230:74-85; discussion 85-93.
41. Petitti N, Etgen AM. -1-Adrenoceptor augmentation of -stimulated cAMP formation is enhanced by estrogen and reduced by progesterone in rat hypothalamic slices. J Neurosci. 1990;10:2842-2849.
42. Wagner HR, Crutcher KA, Davis JN. Chronic estrogen treatment decreases -Adrenergic responses in rat cerebral cortex. Brain Res. 1979;171:147-151.
43. Wilkinson M, Bhanot R, Wilkinson DA, Brawer Jr. Prolonged estrogen treatment induces changes in opiate, benzodiazepine and -Adrenergic binding sites in female rat hypothalamus. Brain Res Bull. 1983;11:279-281.
44. Atz M, Walsh D, Cartagena P, et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods. 2007;163:295-309.
45. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci. 2005;25:5066-5078.
46. Meitzen J, Luoma JL, Stern CM, Mermelstein PG. ß1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons. J Neurochem. 2011;116:984-995.
47. Mong JA, Glaser E, McCarthyMM.Gonadal steroids promote glial differentiation and alter neuronal morphology in the developing hypothalamus in a regionally specific manner. J Neurosci. 1999;19: 1464-1472.
48. Hu M, Becker JB. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci. 2003;23:693-699.
49. Groth RD, Weick JP, Bradley KC, et al. D1 dopamine receptor activation of NFAT-mediated striatal gene expression. Eur J Neurosci. 2008;27:31-42.
50. Meitzen J, Grove DD, Mermelstein PG. The organizational and aromatization hypotheses apply to rapid, nonclassical hormone action: neonatal masculinization eliminates rapid estradiol action in female hippocampal neurons. Endocrinology. 2012;153:4616-4621.
51. Mermelstein PG, Bito H, Deisseroth K, Tsien RW. Critical dependence of cAMP response element-binding protein phosphorylation on L-type calcium channels supports a selective response to EPSPs in preference to action potentials. J Neurosci. 2000;20:266-273.
52. Stern CM, Luoma JI, Meitzen J, Mermelstein PG. Corticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel G-signaling pathway. PLoS One. 2011;6:e18114.
53. Mermelstein PG, Deisseroth K, Dasgupta N, Isaksen AL, Tsien RW. Calmodulin priming: nuclear translocation of a calmodulin complex and the memory of prior neuronal activity. Proc Natl Acad Sci U S A. 2001;98:15342-15347.
54. Fels E, Bosch LR. Effect of prenatal administration of testosterone on ovarian function in rats. Am J Obstet Gynecol. 1971;111:964-969.
55. Lamond DR. Alteration of ovarian function of immature mice treated with androgen after birth. J Endocrinol. 1969;43:319-320.
56. Hara M, Fukui R, Hieda E, et al. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. J Neurochem. 2010;113:1046-1059.
57. Shelton DL, Reichardt LF. Studies on the expression of the-nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Natl Acad Sci U S A. 1986;83:2714-2718.
58. Martínez HJ, Dreyfus CF, Jonakait GM, Black IB. Nerve growth factor promotes cholinergic development in brain striatal cultures. Proc Natl Acad Sci U S A. 1985;82:7777-7781.
59. Chesley LC, Talledo E, Bohler CS, Zuspan FP. Vascular reactivity to angiotensin II and norepinephrine in pregnant women. Am J Obstet Gynecol. 1965;91:837-842.
60. Riemer RK, Wu YY, Bottari SP, Jacobs MM, Goldfien A, Roberts JM. Estrogen reduces -Adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium. Mol Pharmacol. 1988;33:389-395.
61. Monjo M, Rodríguez AM, Palou A, Roca P. Direct effects of testosterone, 17-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis. Endocrinology. 2003;144:4923-4930.
62. Pinos H, Collado P, Rodríguez-Zafra M, RodríguezC, Segovia S, Guillamón A. The development of sex differences in the locus coeruleus of the rat. Brain Res Bull. 2001;56:73-78.
63. Almey A, Filardo EJ, Milner TA, Brake WG. Estrogen receptors are found in glia and at extranuclear neuronal sites in the dorsal striatum of female rats: evidence for cholinergic but not dopaminergic colocalization. Endocrinology. 2012;153:5373-5383.
64. Di Paolo T, Rouillard C, Bédard P. 17-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol. 1985;117:197-203.
65. Grove-Strawser D, Boulware MI, Mermelstein PG. Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience. 2010;170: 1045-1055.
66. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci. 1996;16:595-604.
67. Forlano PM, Woolley CS. Quantitative analysis of pre-And postsynaptic sex differences in the nucleus accumbens. J Comp Neurol. 2010;518:1330-1348.
68. Meitzen J, Pflepsen KR, Stern CM, Meisel RL, Mermelstein PG. Measurements of neuron soma size and density in rat dorsal striatum, nucleus accumbens core and nucleus accumbens shell: differences between striatal region and brain hemisphere, but not sex. Neurosci Lett. 2011;487:177-181.
69. Staffend NA, Loftus CM, Meisel RL. Estradiol reduces dendritic spine density in the ventral striatum of female Syrian hamsters. Brain Struct Funct. 2011;215:187-194.
70. Wissman AM, McCollum AF, Huang GZ, Nikrodhanond AA, Woolley CS. Sex differences and effects of cocaine on excitatory synapses in the nucleus accumbens. Neuropharmacology. 2011;61: 217-227.
71. Wagner HR, Davies JN. Decreased -Adrenergic responses in the female rat brain are eliminated by ovariectomy: correlation of [3H]dihydroalprenolol binding and catecholamine stimulated cyclic AMP levels. Brain Res. 1980;201:235-239.
72. Pisani A, Bonsi P, Centonze D, et al. Activation of-1-Adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway. J Neurosci. 2003;23: 5272-5282.
73. McKittrick CR, Abercrombie ED. Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J Neurochem. 2007;100:1247-1256.
74. Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci. 1979;2:113-168.
75. Weinshenker D, Schroeder JP. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology. 2007; 32:1433-1451.
76. Rommelfanger KS, Weinshenker D. Norepinephrine: the redheaded stepchild of Parkinson's disease. Biochem Pharmacol. 2007;74: 177-190.
77. Harris GC, Hedaya MA, Pan WJ, Kalivas P. -Adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology. 1996;14:195-204.
78. Lindenbach D, Ostock CY, Eskow Jaunarajs KL, Dupre KB, Barnum CJ, Bhide N, Bishop C.et al. Behavioral and cellular modulation of L-DOPA-induced dyskinesia by -Adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat. J Pharmacol Exp Ther. 2011; 337:755-765.
79. Cornil CA, Ball GF. Interplay among catecholamine systems: dopamine binds to -2-Adrenergic receptors in birds and mammals. J Comp Neurol. 2008;511:610-627.
80. Malenka RC, Nicoll RA. Dopamine decreases the calcium-Activated afterhyperpolarization in hippocampal CA1 pyramidal cells. Brain Res. 1986;379:210-215.
81. Zhang W, Klimek V, Farley JT, Zhu MY, Ordway GA. -2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther. 1999;289:1286-1292.
82. Becker JB. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav. 1999;64:803-812.
83. Küppers E, Krust A, Chambon P, Beyer C. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-α knockout (ERKO) mice. Psychoneuroendocrinology. 2008;33:832-838.
84. Andersen SL, RutsteinM,Benzo JM, Hostetter JC, TeicherMH.Sex differences in dopamine receptor overproduction and elimination. Neuroreport. 1997;8:1495-1498.
85. Bazzett TJ, Becker JB. Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res. 1994;637:163-172.
86. Le Saux M, Morissette M, Di Paolo T. ER-mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology. 2006;50:451-457.
87. Parellada E, Lomeña F, Catafau AM, et al. Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study. Psychiatry Res. 2004;130: 79-84.
88. ZappiaM,Annesi G, Nicoletti G, et al. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch Neurol. 2005;62:601-605.
89. Carpentier AF, Bonnet AM, Vidailhet M, Agid Y. Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease. Neurology. 1996;46:1548-1551.
90. ZappiaM,Albanese A, Bruno E, et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol. 2013;260:714-740.